TABLE 3.
Assay | CFHE1 | CFHE2 | Reference compound a |
---|---|---|---|
TEAC | 4.17 (3.40–5.11) ψ , § | 5.65 (4.46–7.17) § | 2.93 (1.80–4.38) |
ORAC | 12.51 (6.82–22.93) ψ , § | 56.73 (25.65–125.44) § | 0.67 (0.31–1.22) |
β‐Carotene bleaching | 18.05 (14.20–22.96) ψ , § | 17.28 (12.51–23.88) § | 0.18 (0.09–0.36) |
Iron‐chelating activity | 63.43 (49.12–81.91) ψ, § | 33.02 (24.64–44.26) § | 6.59 (5.21–8.04) |
FRAP | 80.21 (43.56–147.69) ψ , § | 144.86 (118.12–177.65) § | 3.73 (1.68–7.59) |
DPPH | 254.10 (177.50–363.75) ψ , § | 317.23 (207.35–485.34) § | 3.82 (1.12–5.38) |
Trolox for trolox equivalent antioxidant capacity (TEAC), oxygen radical absorbance capacity (ORAC), ferric reducing antioxidant power (FRAP) and 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) assays; butylhydroxytoluene (BHT) for β‐carotene bleaching assay; ethylenediaminetetraacetic acid (EDTA) for iron‐chelating activity.
p < .001 versus CFHE2.
p < .001 versus reference compound.